List of Tables
    Table 1. Recombinant Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Recombinant Vaccines Market Trends
    Table 3. Recombinant Vaccines Market Drivers
    Table 4. Recombinant Vaccines Market Challenges
    Table 5. Recombinant Vaccines Market Restraints
    Table 6. Global Recombinant Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Recombinant Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Recombinant Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Recombinant Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Recombinant Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Recombinant Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Recombinant Vaccines Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Recombinant Vaccines Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Recombinant Vaccines Sales Share by Manufacturer, 2017-2022
    Table 15. Global Recombinant Vaccines Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Recombinant Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Recombinant Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Vaccines as of 2021)
    Table 18. Top Players of Recombinant Vaccines in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Recombinant Vaccines Product Type
    Table 20. Date of International Manufacturers Enter into Recombinant Vaccines Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Recombinant Vaccines Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Recombinant Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Recombinant Vaccines Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Recombinant Vaccines Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Recombinant Vaccines Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Recombinant Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Recombinant Vaccines Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Recombinant Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Recombinant Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Recombinant Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Recombinant Vaccines Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Recombinant Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Recombinant Vaccines Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Recombinant Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Recombinant Vaccines Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Recombinant Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Recombinant Vaccines Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Recombinant Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Recombinant Vaccines Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Recombinant Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Merck & Co., Inc Corporation Information
    Table 43. Merck & Co., Inc Description and Business Overview
    Table 44. Merck & Co., Inc Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Merck & Co., Inc Recombinant Vaccines Product
    Table 46. Merck & Co., Inc Recent Development
    Table 47. Green Cross Corporation Corporation Information
    Table 48. Green Cross Corporation Description and Business Overview
    Table 49. Green Cross Corporation Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Green Cross Corporation Product
    Table 51. Green Cross Corporation Recent Development
    Table 52. Pfizer Inc. Corporation Information
    Table 53. Pfizer Inc. Description and Business Overview
    Table 54. Pfizer Inc. Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Pfizer Inc. Product
    Table 56. Pfizer Inc. Recent Development
    Table 57. Bayer AG Corporation Information
    Table 58. Bayer AG Description and Business Overview
    Table 59. Bayer AG Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Bayer AG Product
    Table 61. Bayer AG Recent Development
    Table 62. Sanofi S A. Corporation Information
    Table 63. Sanofi S A. Description and Business Overview
    Table 64. Sanofi S A. Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Sanofi S A. Product
    Table 66. Sanofi S A. Recent Development
    Table 67. Protein Science Corporation Corporation Information
    Table 68. Protein Science Corporation Description and Business Overview
    Table 69. Protein Science Corporation Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Protein Science Corporation Product
    Table 71. Protein Science Corporation Recent Development
    Table 72. GlaxoSmithKline Plc. Corporation Information
    Table 73. GlaxoSmithKline Plc. Description and Business Overview
    Table 74. GlaxoSmithKline Plc. Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. GlaxoSmithKline Plc. Product
    Table 76. GlaxoSmithKline Plc. Recent Development
    Table 77. Novartis AG Corporation Information
    Table 78. Novartis AG Description and Business Overview
    Table 79. Novartis AG Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Novartis AG Product
    Table 81. Novartis AG Recent Development
    Table 82. Bharat Biotech Corporation Information
    Table 83. Bharat Biotech Description and Business Overview
    Table 84. Bharat Biotech Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Bharat Biotech Product
    Table 86. Bharat Biotech Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Recombinant Vaccines Customers List
    Table 90. Recombinant Vaccines Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Vaccines Product Picture
    Figure 2. Global Recombinant Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Recombinant Vaccines Market Size 2017-2028 (US$ Million)
    Figure 4. Global Recombinant Vaccines Sales 2017-2028 (K Units)
    Figure 5. United States Recombinant Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Recombinant Vaccines Market Size 2017-2028 (US$ Million)
    Figure 7. United States Recombinant Vaccines Sales 2017-2028 (K Units)
    Figure 8. United States Recombinant Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Recombinant Vaccines Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Recombinant Vaccines Report Years Considered
    Figure 11. Product Picture of Subunit Recombinant Vaccines
    Figure 12. Product Picture of Attenuated Recombinant Vaccines
    Figure 13. Product Picture of Vector Recombinant Vaccines
    Figure 14. Global Recombinant Vaccines Market Share by Type in 2022 & 2028
    Figure 15. Global Recombinant Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Recombinant Vaccines Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Recombinant Vaccines Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Recombinant Vaccines Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Recombinant Vaccines Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Recombinant Vaccines Market Share by Type in 2022 & 2028
    Figure 21. United States Recombinant Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Recombinant Vaccines Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Recombinant Vaccines Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Recombinant Vaccines Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Recombinant Vaccines Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Recombinant Human Vaccines
    Figure 27. Product Picture of Animal Recombinant Vaccines
    Figure 28. Global Recombinant Vaccines Market Share by Application in 2022 & 2028
    Figure 29. Global Recombinant Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Recombinant Vaccines Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Recombinant Vaccines Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Recombinant Vaccines Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Recombinant Vaccines Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Recombinant Vaccines Market Share by Application in 2022 & 2028
    Figure 35. United States Recombinant Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Recombinant Vaccines Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Recombinant Vaccines Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Recombinant Vaccines Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Recombinant Vaccines Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Recombinant Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Recombinant Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Recombinant Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Recombinant Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Recombinant Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Recombinant Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Recombinant Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Recombinant Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Recombinant Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Recombinant Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Recombinant Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Recombinant Vaccines Value Chain
    Figure 74. Recombinant Vaccines Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed